• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-145 通过靶向 c-Myc 和 Cdk6 抑制口腔鳞状细胞癌(OSCC)细胞生长。

MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6.

机构信息

Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong, Xi'an 710061, the People's Republic of China.

出版信息

Cancer Cell Int. 2013 May 28;13(1):51. doi: 10.1186/1475-2867-13-51.

DOI:10.1186/1475-2867-13-51
PMID:23710609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3680295/
Abstract

BACKGROUND

MicroRNAs (miRNAs) are a large group of negative gene regulators that potentially play a critical role in tumorigenesis. Increasing evidences indicate that miR-145 acts a tumor suppressor in numerous human cancers. However, its role in oral carcinogenesis remains poorly defined. The aim of this study is to determine expression levels of miR-145 in oral squamous cell carcinomas (OSCCs) and normal mucosa tissues, and explore its biological functions in OSCCs.

METHODS

Reverse transcription quantitative real-time PCR (RT-qPCR) assay was used to evaluate expression levels of miR-145. The biological functions of miR-145 were determined by cell proliferation and colony formation, cell cycle and apoptosis, as well as cell invasion assay.

RESULTS

MiR-145 was frequently down-regulated in OSCCs compared with normal mucosa tissues. Restoring miR-145 expression in OSCC cells dramatically suppressed cell proliferation and colony formation, and induced G1 phase arrest and cell apoptosis. Importantly, our data showed that miR-145 downregulated the expression of c-Myc and Cdk6, which have previously been identified as two direct targets of miR-145.

CONCLUSIONS

Our data suggest that miR-145 exerts its tumor suppressor function by targeting c-Myc and Cdk6, leading to the inhibition of OSCC cell growth. MiR-145 rescue may thus be a rational for diagnostic and therapeutic applications in OSCC.

摘要

背景

MicroRNAs(miRNAs)是一大类负向基因调控因子,它们在肿瘤发生中可能发挥关键作用。越来越多的证据表明,miR-145 在许多人类癌症中作为肿瘤抑制因子发挥作用。然而,其在口腔癌发生中的作用仍未明确。本研究旨在确定 miR-145 在口腔鳞状细胞癌(OSCCs)和正常黏膜组织中的表达水平,并探讨其在 OSCCs 中的生物学功能。

方法

采用逆转录定量实时 PCR(RT-qPCR)检测 miR-145 的表达水平。通过细胞增殖和集落形成、细胞周期和凋亡以及细胞侵袭实验来确定 miR-145 的生物学功能。

结果

miR-145 在 OSCCs 中较正常黏膜组织常下调。在 OSCC 细胞中恢复 miR-145 表达可显著抑制细胞增殖和集落形成,并诱导 G1 期阻滞和细胞凋亡。重要的是,我们的数据表明,miR-145 下调了 c-Myc 和 Cdk6 的表达,这两种蛋白先前已被鉴定为 miR-145 的两个直接靶标。

结论

我们的数据表明,miR-145 通过靶向 c-Myc 和 Cdk6 发挥其肿瘤抑制功能,从而抑制 OSCC 细胞生长。miR-145 恢复可能是 OSCC 诊断和治疗应用的合理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89b/3680295/b8868b206753/1475-2867-13-51-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89b/3680295/f718f1eed212/1475-2867-13-51-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89b/3680295/f76cc4d42e5e/1475-2867-13-51-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89b/3680295/f35db723ba34/1475-2867-13-51-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89b/3680295/3128fc75e348/1475-2867-13-51-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89b/3680295/0461c56112d0/1475-2867-13-51-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89b/3680295/b8868b206753/1475-2867-13-51-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89b/3680295/f718f1eed212/1475-2867-13-51-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89b/3680295/f76cc4d42e5e/1475-2867-13-51-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89b/3680295/f35db723ba34/1475-2867-13-51-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89b/3680295/3128fc75e348/1475-2867-13-51-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89b/3680295/0461c56112d0/1475-2867-13-51-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89b/3680295/b8868b206753/1475-2867-13-51-6.jpg

相似文献

1
MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6.miR-145 通过靶向 c-Myc 和 Cdk6 抑制口腔鳞状细胞癌(OSCC)细胞生长。
Cancer Cell Int. 2013 May 28;13(1):51. doi: 10.1186/1475-2867-13-51.
2
miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.微小RNA-433通过靶向组蛋白去乙酰化酶6抑制口腔鳞状细胞癌(OSCC)细胞的生长和转移。
Oral Oncol. 2015 Jul;51(7):674-82. doi: 10.1016/j.oraloncology.2015.04.010. Epub 2015 May 8.
3
MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6.MicroRNA-504 通过靶向 CDK6 抑制口腔鳞状细胞癌中的细胞增殖、迁移和侵袭,发挥肿瘤抑制作用。
Int J Biochem Cell Biol. 2020 Feb;119:105663. doi: 10.1016/j.biocel.2019.105663. Epub 2019 Dec 5.
4
Decrease expression of microRNA-744 promotes cell proliferation by targeting c-Myc in human hepatocellular carcinoma.miR-744 表达下调通过靶向 c-Myc 促进人肝癌细胞增殖。
Cancer Cell Int. 2014 Jun 22;14:58. doi: 10.1186/1475-2867-14-58. eCollection 2014.
5
MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.miR-132 通过靶向 TGF-β1 抑制顺铂耐药口腔鳞状细胞癌细胞的迁移和侵袭并增加其化疗敏感性。
Bioengineered. 2020 Dec;11(1):91-102. doi: 10.1080/21655979.2019.1710925.
6
MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.微小RNA-375通过靶向胰岛素样生长因子1受体抑制口腔鳞状细胞癌的生长并增强其放射敏感性。
Cell Physiol Biochem. 2017;42(5):2105-2117. doi: 10.1159/000479913. Epub 2017 Aug 15.
7
MiR-181d functions as a potential tumor suppressor in oral squamous cell carcinoma by targeting K-ras.微小RNA-181d通过靶向K-ras基因,在口腔鳞状细胞癌中发挥潜在抑癌作用。
Int J Clin Exp Pathol. 2017 Jul 1;10(7):7847-7855. eCollection 2017.
8
MiR-106a* inhibits oral squamous cell carcinoma progression by directly targeting MeCP2 and suppressing the Wnt/β-Catenin signaling pathway.微小RNA-106a*通过直接靶向甲基化CpG结合蛋白2并抑制Wnt/β-连环蛋白信号通路来抑制口腔鳞状细胞癌的进展。
Am J Transl Res. 2018 Nov 15;10(11):3542-3554. eCollection 2018.
9
miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2.miR-23a-3p 通过靶向 FGF2 抑制口腔鳞状细胞癌的细胞增殖,且与较好的预后相关:miR-23a-3p 通过靶向 FGF2 抑制口腔鳞状细胞癌的生长。
Pathol Res Pract. 2019 Apr;215(4):660-667. doi: 10.1016/j.prp.2018.12.021. Epub 2018 Dec 24.
10
miRNA-101 acts as a tumor suppressor in oral squamous cell carcinoma by targeting CX chemokine receptor 7.微小RNA-101通过靶向CXC趋化因子受体7在口腔鳞状细胞癌中发挥肿瘤抑制作用。
Am J Transl Res. 2016 Nov 15;8(11):4902-4911. eCollection 2016.

引用本文的文献

1
miR‑145 and miR‑23b co‑transfection decreases proliferation, migration, invasion and protein levels of c‑MYC, ZEB1 and ABCB1 in epithelial ovarian cancer cell lines.miR-145和miR-23b共转染可降低上皮性卵巢癌细胞系中c-MYC、ZEB1和ABCB1的增殖、迁移、侵袭及蛋白水平。
Mol Med Rep. 2025 Sep;32(3). doi: 10.3892/mmr.2025.13611. Epub 2025 Jul 11.
2
Decoding Salivary ncRNAomes as Novel Biomarkers for Oral Cancer Detection and Prognosis.解码唾液非编码RNA组作为口腔癌检测和预后的新型生物标志物
Noncoding RNA. 2025 Mar 20;11(2):28. doi: 10.3390/ncrna11020028.
3
The Suppression of the Epithelial to Mesenchymal Transition in Prostate Cancer through the Targeting of MYO6 Using MiR-145-5p.

本文引用的文献

1
microRNA Regulation and Its Consequences in Cancer.微小RNA调控及其在癌症中的后果
Curr Pathobiol Rep. 2013 Mar;1(1):71-79. doi: 10.1007/s40139-012-0002-7. Epub 2012 Dec 18.
2
MicroRNAs in human cancer.人类癌症中的 microRNAs。
Adv Exp Med Biol. 2013;774:1-20. doi: 10.1007/978-94-007-5590-1_1.
3
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.NEDD9是miR-145的一个新靶点,它会增加胶质母细胞瘤的侵袭性。
通过使用MiR-145-5p靶向MYO6抑制前列腺癌上皮-间质转化
Int J Mol Sci. 2024 Apr 12;25(8):4301. doi: 10.3390/ijms25084301.
4
Differential Expression of MicroRNA MiR-145 and MiR-155 Downstream Targets in Oral Cancers Exhibiting Limited Chemotherapy Resistance.在表现出有限化疗耐药性的口腔癌中,miR-145 和 miR-155 的下游靶基因的差异表达。
Int J Mol Sci. 2024 Feb 10;25(4):2167. doi: 10.3390/ijms25042167.
5
Panoramic view of key cross-talks underpinning the oral squamous cell carcinoma stemness - unearthing the future opportunities.支撑口腔鳞状细胞癌干性的关键相互作用全景——挖掘未来机遇。
Front Oncol. 2023 Dec 19;13:1247399. doi: 10.3389/fonc.2023.1247399. eCollection 2023.
6
Expression of miR-145 and miR-18b in Peripheral Blood Samples of Head and Neck Cancer Patients.miR-145和miR-18b在头颈癌患者外周血样本中的表达
Indian J Clin Biochem. 2023 Oct;38(4):528-535. doi: 10.1007/s12291-023-01119-2. Epub 2023 Feb 7.
7
MicroRNA-1289 Functions as a Novel Tumor Suppressor in Oral Squamous Cell Carcinoma.微小RNA-1289在口腔鳞状细胞癌中作为一种新型肿瘤抑制因子发挥作用。
Cancers (Basel). 2023 Aug 17;15(16):4138. doi: 10.3390/cancers15164138.
8
Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications.口腔癌中的非编码RNA:新兴作用与临床应用
Cancers (Basel). 2023 Jul 25;15(15):3752. doi: 10.3390/cancers15153752.
9
Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy.循环微RNA作为口腔癌液体活检中的生物标志物
Biomedicines. 2023 Mar 21;11(3):965. doi: 10.3390/biomedicines11030965.
10
Prognostic utility of microRNA-145 and CD 133 in oral squamous cell carcinoma: A pilot study from Northern India.微小RNA-145和CD133在口腔鳞状细胞癌中的预后效用:来自印度北部的一项初步研究。
J Oral Biol Craniofac Res. 2023 Mar-Apr;13(2):92-95. doi: 10.1016/j.jobcr.2022.11.008. Epub 2022 Dec 2.
Oncotarget. 2012 Jul;3(7):723-34. doi: 10.18632/oncotarget.547.
4
The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer.miR-143/-145 簇调节膀胱癌中的纤溶酶原激活物抑制剂-1。
Br J Cancer. 2012 Jan 17;106(2):366-74. doi: 10.1038/bjc.2011.520. Epub 2011 Nov 22.
5
MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis.miR-145 可直接靶向作用于肿瘤细胞中的 p70S6K1,从而抑制肿瘤生长和血管生成。
Nucleic Acids Res. 2012 Jan;40(2):761-74. doi: 10.1093/nar/gkr730. Epub 2011 Sep 14.
6
EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators.EGFR 信号下调西方饮食促进的小鼠结肠癌中的肿瘤抑制因子 miR-143 和 miR-145:G1 调节因子的作用。
Mol Cancer Res. 2011 Jul;9(7):960-75. doi: 10.1158/1541-7786.MCR-10-0531. Epub 2011 Jun 8.
7
MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.微小 RNA-145 在前列腺癌中受 DNA 甲基化和 p53 基因突变的调控。
Carcinogenesis. 2011 May;32(5):772-8. doi: 10.1093/carcin/bgr036. Epub 2011 Feb 23.
8
The molecular biology of head and neck cancer.头颈部癌症的分子生物学。
Nat Rev Cancer. 2011 Jan;11(1):9-22. doi: 10.1038/nrc2982. Epub 2010 Dec 16.
9
Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway.致癌性 Ras 对 miR-143/145 簇的抑制作用启动了促肿瘤发生的正反馈通路。
Genes Dev. 2010 Dec 15;24(24):2754-9. doi: 10.1101/gad.1950610.
10
miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc.miRNA-145 通过靶向 c-Myc 抑制非小细胞肺癌细胞增殖。
J Exp Clin Cancer Res. 2010 Nov 22;29(1):151. doi: 10.1186/1756-9966-29-151.